Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-01 Sale |
2021-07-02 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $564.5 | $56,450 | 23,491 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
2,558 | $575 | $1,470,850 | 8,568 (Direct) |
View |
| 2021-06-25 Sale |
2021-06-28 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,084 | $549 | $1,144,116 | 15,240 (Indirect Direct) |
View |
| 2021-06-21 Sale |
2021-06-23 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
80,000 | $538.9 | $43,112,141 | 1,226,404 (Indirect Direct) |
View |
| 2021-06-14 Sale |
2021-06-16 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $524.76 | $52,476 | 23,591 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-16 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,700 | $525 | $892,500 | 17,324 (Indirect Direct) |
View |
| 2021-06-07 Sale |
2021-06-08 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
1,930 | $525 | $1,013,250 | 8,322 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-08 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $511.65 | $511,650 | 33,146 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-18 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
17,521 | $519.46 | $9,101,460 | 111,701 (Indirect Direct) |
View |
| 2021-05-07 Sale |
2021-05-10 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $495.63 | $495,630 | 34,146 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-02 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $506.92 | $50,692 | 23,691 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,480 | $554.32 | $1,374,714 | 17,719 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 4:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $483.6 | $48,360 | 27,404 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 4:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $520.48 | $52,048 | 23,643 (Direct) |
View |
| 2020-11-17 Sale |
2020-11-18 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,628 | $542.73 | $3,597,188 | 51,378 (Indirect Direct) |
View |
| 2020-11-02 Sale |
2020-11-03 5:22 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $548.54 | $54,854 | 23,743 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-01 Exercise |
2021-07-02 4:01 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
2,558 | $0 | 8,568 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
2,558 | $391.92 | 8,568 (Direct) |
View |
| 2021-06-25 Exercise |
2021-06-28 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,084 | $371.4 | 15,240 (Direct) |
View |
| 2021-06-25 Exercise |
2021-06-28 4:01 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,084 | $0 | 15,240 (Direct) |
View |
| 2021-04-15 Gift |
2021-06-23 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
120,874 | $0 | 1,226,404 (Indirect) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,700 | $371.4 | 17,324 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:02 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,700 | $0 | 17,324 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
1,930 | $374.12 | 8,322 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:03 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
1,930 | $0 | 8,322 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:02 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 33,146 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 33,146 (Direct) |
View |
| 2021-02-25 Gift |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
435 | $0 | 111,701 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 4:04 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
52,500 | $0 | 111,701 (Direct) |
View |
| 2021-05-14 Tax Withholding |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
34,979 | $516.69 | 111,701 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
40,000 | $179.13 | 111,701 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
12,500 | $52.03 | 111,701 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-10 4:02 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 34,146 (Direct) |
View |
| 2021-05-07 Exercise |
2021-05-10 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 34,146 (Direct) |
View |
| 2021-01-19 Gift |
2021-02-24 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
414 | $0 | 545,495 (Indirect) |
View |
| 2021-02-23 Exercise |
2021-02-24 4:02 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
250,000 | $0 | 545,495 (Direct) |
View |
| 2021-02-23 Tax Withholding |
2021-02-24 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
137,998 | $458.48 | 545,495 (Direct) |
View |
| 2021-02-23 Exercise |
2021-02-24 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
250,000 | $52.03 | 545,495 (Direct) |
View |
| 2021-02-17 Conversion |
2021-02-18 4:01 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | REGENERON PHARMACEUTICALS INC. 10% Owner |
28,597,314 | $0 | 2,097,314 (Direct) |
View |
Ownership |
2021-02-11 5:01 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | REGENERON PHARMACEUTICALS INC. 10% Owner |
0 | $0 | 2,097,314 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 4:06 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,480 | $0 | 17,719 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,480 | $380.95 | 17,719 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:53 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,861 | $0 | 18,853 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:32 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
3,861 | $0 | 63,526 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:11 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
3,861 | $0 | 4,504 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:11 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
3,861 | $0 | 5,691 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:11 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
3,861 | $0 | 5,294 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:11 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
3,861 | $0 | 4,515 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:11 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
3,861 | $0 | 4,504 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:09 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
3,861 | $0 | 27,404 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:07 pm |
N/A 2031-01-04 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
3,861 | $0 | 9,504 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
620,270 | $0 | 620,270 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
620,270 | $0 | 620,270 (Direct) |
View |
| 2020-07-27 Gift |
2020-12-31 5:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
57,465 | $0 | 1,362,968 (Indirect) |
View |
| 2020-12-30 Exercise |
2020-12-31 5:30 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
398,079 | $0 | 1,362,968 (Direct) |
View |
| 2020-12-30 Tax Withholding |
2020-12-31 5:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
216,810 | $483.25 | 1,362,968 (Direct) |
View |
| 2020-12-30 Exercise |
2020-12-31 5:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
398,079 | $52.03 | 1,362,968 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:07 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
35,214 | $0 | 86,592 (Direct) |
View |
| 2020-10-06 Gift |
2020-12-11 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
2,755 | $0 | 270,588 (Indirect) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:06 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
30,119 | $0 | 270,588 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:06 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr Industrial O |
26,880 | $0 | 47,909 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:05 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion SVP Commercial |
28,075 | $0 | 42,128 (Direct) |
View |
| 2020-02-26 Gift |
2020-12-11 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
750 | $0 | 57,115 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:05 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
19,188 | $0 | 57,115 (Direct) |
View |
| 2020-09-24 Gift |
2020-12-11 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. VP Controller |
75 | $0 | 36,317 (Indirect) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:05 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. VP Controller |
12,719 | $0 | 36,317 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:04 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
21,880 | $0 | 46,055 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:03 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
21,880 | $0 | 36,605 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
13,736 | $30.63 | 51,378 (Direct) |
View |
| 2020-11-16 Tax Withholding |
2020-11-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
7,108 | $561.39 | 51,378 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:02 pm |
N/A 2020-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
13,736 | $0 | 51,378 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-13 5:57 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
11 | $345.47 | 13,693 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-13 5:57 pm |
N/A 2027-01-27 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
11 | $0 | 13,693 (Direct) |
View |
| 2019-11-22 Gift |
2020-11-03 5:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
4,500 | $0 | 23,743 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
3,264 | $30.63 | 51,378 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 4:02 pm |
N/A 2020-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
5,185 | $0 | 51,378 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
1,921 | $52.03 | 51,378 (Direct) |
View |